Jacobs Levy Equity Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-110,594
Closed -$17.6M – 1101
2025
Q1
$17.6M Sell
110,594
-99,566
-47% -$18M 0.07% 245
2024
Q4
$39M Buy
210,160
+188,492
+870% +$36.6M 0.14% 152
2024
Q3
$4.57M Sell
21,668
-3,047
-12% -$529K 0.02% 455
2024
Q2
$3.31M Buy
24,715
+3,697
+18% +$700K 0.01% 511
2024
Q1
$4.51M Buy
+21,018
New +$4.12M 0.02% 448
2023
Q4
– Sell
-25,559
Closed -$5.07M – 1021
2023
Q3
$5.07M Sell
25,559
-3,585
-12% -$904K 0.03% 374
2023
Q2
$9.46M Sell
29,144
-1,464
-5% -$418K 0.05% 284
2023
Q1
$7.16M Sell
30,608
-45,330
-60% -$11.5M 0.04% 336
2022
Q4
$19.1M Sell
75,938
-13,269
-15% -$2.83M 0.13% 197
2022
Q3
$15.8M Buy
+89,207
New +$17.9M 0.13% 198
2021
Q3
– Sell
-2,735
Closed -$529K – 1080
2021
Q2
$529K Sell
2,735
-19,228
-88% -$3.81M ﹤0.01% 850
2021
Q1
$4.55M Sell
21,963
-1,429
-6% -$304K 0.04% 432
2020
Q4
$4.4M Sell
23,392
-2,000
-8% -$327K 0.04% 417
2020
Q3
$3.28M Sell
25,392
-2,698
-10% -$297K 0.03% 430
2020
Q2
$2.44M Sell
28,090
-3,611
-11% -$278K 0.03% 483
2020
Q1
$1.91M Buy
31,701
+8,291
+35% +$614K 0.02% 484
2019
Q4
$1.74M Sell
23,410
-9,230
-28% -$593K 0.02% 571
2019
Q3
$1.99M Sell
32,640
-460
-1% -$30.3K 0.02% 512
2019
Q2
$2.01M Buy
33,100
+13,900
+72% +$749K 0.03% 522
2019
Q1
$1.09M Buy
+19,200
New +$1.04M 0.02% 640

Other funds holding INSP

Jacobs Levy Equity Management's INSP Position: Q2 2025 in Review

Jacobs Levy Equity Management sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 110,594 shares — an estimated $17.6M sold.

Jacobs Levy Equity Management first reported a position in INSP in Q1 2019 and held it in 20 quarters. The position peaked at $39M in Q4 2024. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

  • Jacobs Levy Equity Management reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 110,594 Inspire Medical Systems shares in Q2 2025, an estimated $17.6M.
  • Jacobs Levy Equity Management first reported a position in Inspire Medical Systems in Q1 2019 and held it in 20 quarters.
  • Jacobs Levy Equity Management's Inspire Medical Systems position peaked at $39M in Q4 2024.
  • 356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2025, filed 14 Aug 2025.